title: A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, OH 45267-0714, USA.
authors.forename: M B
authors.initials: MB
authors.lastname: Shah
authors.forename: J E
authors.initials: JE
authors.lastname: Martin
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
authors.forename: M R
authors.initials: MR
authors.lastname: First
mesh_terms: D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D012449:Safety
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine